Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexmedetomidine for postoperative sleep and recovery after laparoscopic radical surgery for gastric or colorectal cancer
ChiCTR2100054060Phase 4Recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Dec 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and sufentanil in gastric cancer (GC) and colorectal cancer (CRC) (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: Sleep quality of patients, Night sleep and 5 more. Started Dec 2021; status: recruiting.
02
Drugs
dexmedetomidinesufentanil
03
Conditions
gastric cancer (GC)colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2100054060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054060.